Latest Breaking News On - Noetic psychedelic fund - Page 1 : comparemela.com
Woven Science Launches Psychedelic Care Platform with Oversubscribed $8 5M Seed Financing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Woven Science Launch Psychedelic Care Platform with Oversubscribed $8 5M Seed Financing
asiaone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaone.com Daily Mail and Mail on Sunday newspapers.
Woven Science LLC : Woven Science Launches Psychedelic Care Platform with Oversubscribed $8 5M Seed Financing
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Gilgamesh Pharmaceuticals, a biotechnology company that uses psychedelic-related drugs to treat neuropsychiatric disorders, reported Thursday it has raised $27 million in a Series A funding round led by Prime Movers Lab.
Other investors involved in the round included the Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund and Palo Santo Investors.
Prime Movers Lab, a partnership that invests in breakthrough scientific startups, is known for raising funds for inventors in energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture.
With the newly raised capital, New York-based Gilgamesh plans to add more members to its team, including a COO, head of R&D and CBO. It will also work on advancing its programs toward clinical candidate selection and broadening its IP portfolio.
Noetic Fund II LP: Noetic Launches Second Fund to Invest in Emergent Psychedelic Medicine Sector
Having successfully launched one of the first funds operating in the nascent psychedelic medicine space, Toronto-based venture capital firm Noetic is now launching a second, larger Fund.
TORONTO, ON / ACCESSWIRE / March 4, 2021 / The Noetic Funds, founded by the team at Grey House Partners GP Inc., has announced the launch of Noetic Fund II LP ( Fund II ), a venture capital fund that is seeking to raise a minimum of $200mm to invest in early-stage psychedelic and Central Nervous System focused companies addressing global ailments such as mental health conditions, substance use disorders and distinct inflammatory related ailments. The team will build on its investment thesis validated in Noetic Psychedelic Fund LP ( Fund I ), which has provided exceptional returns to date.